DDO-4033

CAT: 0804-HY-175247Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-175247Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DDO-4033 is a SPOP inhibitor (IC50 = 16.9 μM, Kd = 15.1 μM) . DDO-4033 impairs the malignant migration, invasion, and proliferation of clear cell renal cell carcinoma (ccRCC) cell lines. DDO-4033 disrupts SPOP recruitment to its substrate LATS1, inhibits its polyubiquitination and subsequent degradation, and upregulates LATS1 expression. DDO-4033 has promising antitumor activity and is promising for renal cell carcinoma research[1].
UNSPSC
12352005
Target
E1/E2/E3 Enzyme; YAP
Related Pathways
Metabolic Enzyme/Protease; Stem Cell/Wnt
Field of Research
Cancer
Smiles
C#CC1=C([N+]([O-])=O)C=C(C(NC2=CC(C)=NN2C(N3)=NC(CCC)=CC3=O)=O)C=C1
Molecular Formula
C20H18N6O4
Molecular Weight
406.39
References & Citations
[1]Zhang Q, et al. Discovery of 2-Pyrazolylpyrimidinone Derivatives as New SPOP Inhibitors for Renal Cell Carcinoma Therapy. J Med Chem. 2025 Jul 24;68 (14) :14945-14961.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-153331-01DDO-2213
HY-149863DDO-8926
HY-144801ADDO-02005
HY-144634-01DDO-7263
HY-139301-01DDO-5936
HY-132233DDO-2093
HY-155489-01DDO-2728
HY-170668DDO-02267
HY-169947-01DDO-6079
HY-147125DDO-6600

Alternative Products

CatalogName
MF-0119041-01DDO-4033
A-LG-1KG-02LGD-4033
453724-01LGD-4033 discontinued
A14346-200Ligandrol (LGD-4033) 200mg
A14346-5Ligandrol (LGD-4033) 5mg
A14346-100Ligandrol (LGD-4033) 100mg
A14346-10Ligandrol (LGD-4033) 10mg
163355Anti LGD 4033 Pab
A14346-25Ligandrol (LGD-4033) 25mg
A14346-50Ligandrol (LGD-4033) 50mg

Popular Products